Groupama Asset Managment acquired a new stake in Cigna Group (NYSE:CI – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,423 shares of the health services provider’s stock, valued at approximately $987,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. raised its position in shares of Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares in the last quarter. Collier Financial bought a new position in Cigna Group during the third quarter worth $34,000. Founders Capital Management boosted its holdings in Cigna Group by 53.0% in the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after purchasing an additional 53 shares during the period. Traub Capital Management LLC bought a new stake in Cigna Group during the second quarter valued at $48,000. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in Cigna Group during the second quarter valued at $52,000. Institutional investors and hedge funds own 86.99% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on CI shares. UBS Group restated a “buy” rating and issued a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Mizuho set a $325.00 price objective on shares of Cigna Group in a research report on Friday, January 9th. Robert W. Baird dropped their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, TD Cowen lifted their target price on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $333.11.
Cigna Group Trading Down 0.7%
Shares of NYSE:CI opened at $262.83 on Friday. The company has a market cap of $69.26 billion, a PE ratio of 11.85, a P/E/G ratio of 0.92 and a beta of 0.27. The company’s 50-day moving average price is $277.86 and its 200 day moving average price is $281.70. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.
Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same quarter in the prior year, the firm earned $6.64 EPS. Cigna Group’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.
Cigna Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were issued a $1.56 dividend. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. Cigna Group’s dividend payout ratio is currently 28.13%.
Insider Activity at Cigna Group
In other news, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by company insiders.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
